Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 2587.00 | 2022.25 | 1.2793 | 1.3320 | |
| BT-20 | Nilotinib | 0.01 | uM | 4 | 1250.00 | 665.42 | 2082.00 | 2022.25 | 1.0295 | 1.0366 |
| BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 2449.00 | 2022.25 | 1.2110 | 1.2536 | |
| BT-20 | NVP-TAE684 | 0.31623 | uM | 4 | 1250.00 | 665.42 | 2112.00 | 2022.25 | 1.0444 | 1.0549 |
| BT-20 | Etoposide | 0.01 | uM | 4 | 1250.00 | 665.42 | 1934.00 | 2022.25 | 0.9564 | 0.9451 |
| BT-20 | Etoposide | 1 | uM | 4 | 1250.00 | 665.42 | 1333.00 | 2022.25 | 0.6592 | 0.5423 |
| BT-20 | PLX-4720 | 10 | uM | 4 | 1250.00 | 665.42 | 1983.00 | 2022.25 | 0.9806 | 0.9757 |
| BT-20 | Etoposide | 10 | uM | 4 | 1250.00 | 665.42 | 652.00 | 2022.25 | 0.3224 | -0.0126 |
| BT-20 | Nilotinib | 0.0033113 | uM | 4 | 1250.00 | 665.42 | 2192.00 | 2022.25 | 1.0839 | 1.1031 |
| BT-20 | PLX-4720 | 0.01 | uM | 4 | 1250.00 | 665.42 | 2116.00 | 2022.25 | 1.0464 | 1.0573 |
| BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 2081.00 | 2022.25 | 1.0291 | 1.0360 | |
| BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 1498.00 | 2022.25 | 0.7408 | 0.6587 | |
| BT-20 | 0 | uM | 4 | 2500.00 | 1354.79 | 3541.00 | 4293.50 | 0.8247 | 0.7813 | |
| BT-20 | 0 | uM | 4 | 2500.00 | 1354.79 | 3501.00 | 4293.50 | 0.8154 | 0.7692 | |
| BT-20 | Etoposide | 19.9526 | uM | 4 | 2500.00 | 1354.79 | 766.00 | 4293.50 | 0.1784 | -0.2901 |
| BT-20 | 0 | uM | 4 | 2500.00 | 1354.79 | 4116.00 | 4293.50 | 0.9587 | 0.9499 | |
| BT-20 | Nilotinib | 0.1 | uM | 4 | 2500.00 | 1354.79 | 4350.00 | 4293.50 | 1.0132 | 1.0158 |
| BT-20 | PLX-4720 | 0.31623 | uM | 4 | 2500.00 | 1354.79 | 4461.00 | 4293.50 | 1.0390 | 1.0465 |
| BT-20 | Nilotinib | 10 | uM | 4 | 2500.00 | 1354.79 | 1797.00 | 4293.50 | 0.4185 | 0.1850 |
| BT-20 | NVP-TAE684 | 3.1623 | uM | 4 | 2500.00 | 1354.79 | 1615.00 | 4293.50 | 0.3762 | 0.1114 |
| BT-20 | NVP-TAE684 | 10 | uM | 4 | 2500.00 | 1354.79 | 1046.00 | 4293.50 | 0.2436 | -0.1440 |
| BT-20 | PLX-4720 | 3.1623 | uM | 4 | 2500.00 | 1354.79 | 4290.00 | 4293.50 | 0.9992 | 0.9990 |
| BT-20 | PLX-4720 | 1 | uM | 4 | 2500.00 | 1354.79 | 4157.00 | 4293.50 | 0.9682 | 0.9615 |
| BT-20 | Nilotinib | 19.9526 | uM | 4 | 2500.00 | 1354.79 | 2931.00 | 4293.50 | 0.6827 | 0.5900 |
| BT-20 | Nilotinib | 1 | uM | 4 | 2500.00 | 1354.79 | 4205.00 | 4293.50 | 0.9794 | 0.9751 |